Pharma Journalist -

VBI Vaccines Inc. announced the expansion of its hepatitis B (HBV) partnership with Brii Biosciences. Through two license and collaboration agreements, Brii Bio expanded its exclusive…
Read More...

Lifera, a biopharmaceutical company in Saudi Arabia together with Sanofi, one of the world's leading pharmaceutical companies specializing in vaccine development and Arabio announced…
Read More...

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announces an antibody license agreement with Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) specialist developing…
Read More...

Vertex Pharmaceuticals announced that the European Commission has granted approval for the label extension of ORKAMBI (lumacaftor/ivacaftor) for the treatment of children with cystic…
Read More...

F-star Therapeutics, an invoX company, announced that it has entered into a strategic discovery collaboration and licence agreement with Takeda. The collaboration will leverage F-star’s…
Read More...

Baudax Bio, Inc. announced the acquisition of TeraImmune, a privately held a biotechnology company focused on discovery and development of novel Treg-based cell therapies for autoimmune…
Read More...

Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, and its wholly-owned commercialization subsidiary Tonix Medicines, Inc. (Tonix Medicines), announced it has completed…
Read More...

Eli Lilly and Company and Sigilon Therapeutics, Inc. announced a definitive agreement for Lilly to acquire Sigilon, a biopharmaceutical company that seeks to develop functional cures…
Read More...

Bristol Myers Squibb announced that the European Commission (EC) has approved Opdivo (nivolumab) in combination with platinum-based chemotherapy for the neoadjuvant treatment of…
Read More...

Sangamo Therapeutics, Inc., a genomic medicine company, and Voyager Therapeutics, Inc. announced the parties have entered into a definitive license agreement for a potential treatment…
Read More...